arginine vasopressin has been researched along with ethinyl estradiol in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Akerlund, M; Ekström, P; Forsling, M; Kindahl, H; Laudanski, T; Mrugacz, G | 1 |
Akerlund, M; Forsling, ML; Hauksson, A; Kindahl, H | 1 |
Kocsis, J; László, FA; Szabó, E | 1 |
Edwards, A; Fairhall, KM; Lightman, SL; McGarrick, GM; Robinson, IC; Williams, TD | 1 |
Gaillard, RC; Merkelbach, U; Vallotton, MB | 1 |
Bell, ML; Cotter, JD; Rehrer, NJ; Sims, ST | 1 |
7 other study(ies) available for arginine vasopressin and ethinyl estradiol
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Stimulation of vasopressin release in women with primary dysmenorrhoea and after oral contraceptive treatment--effect on uterine contractility.
Topics: Adult; Arginine Vasopressin; Contraceptives, Oral, Hormonal; Dysmenorrhea; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel; Pressure; Uterine Contraction | 1992 |
Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.
Topics: Adolescent; Adult; Arginine Vasopressin; Contraceptives, Oral, Combined; Dinoprost; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Prostaglandins F | 1987 |
Effect of a vasopressin antagonist d(CH2)5Tyr(Met)AVP on the development of renal vasospasm induced by estrin plus vasopressin administration in rats.
Topics: Animals; Arginine Vasopressin; Contraceptives, Oral, Combined; Ethinyl Estradiol; Male; Norethindrone; Premedication; Rats; Renal Artery; Renal Circulation; Vasoconstriction; Vasopressins | 1987 |
Influence of endogenous and exogenous oestrogens on posterior pituitary secretion in women.
Topics: Adult; Anorexia Nervosa; Anovulation; Arginine Vasopressin; Ethinyl Estradiol; Female; Humans; Luteinizing Hormone; Menstrual Cycle; Oxytocin; Pituitary Gland, Posterior; Pituitary Hormones; Polycystic Ovary Syndrome; Radioimmunoassay | 1985 |
Studies of the factors modulating antidiuretic hormone excretion in man in response to the osmolar stimulus: effects of oestrogen and angiotensin II.
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Ethinyl Estradiol; Female; Humans; Male; Osmolar Concentration; Renin; Water-Electrolyte Balance | 1983 |
Endogenous and exogenous female sex hormones and renal electrolyte handling: effects of an acute sodium load on plasma volume at rest.
Topics: Adult; Arginine Vasopressin; Bicycling; Body Water; Contraceptives, Oral, Hormonal; Electrolytes; Ethinyl Estradiol; Female; Follicular Phase; Gonadal Steroid Hormones; Hormones; Humans; Kidney; Levonorgestrel; Luteal Phase; Models, Statistical; Osmotic Pressure; Plasma Volume; Progestins; Rest; Sodium | 2008 |